BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corsetti M, Whorwell P. New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline. Expert Rev Gastroenterol Hepatol 2017;11:285-92. [PMID: 28276811 DOI: 10.1080/17474124.2017.1298442] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Farahbakhsh ZZ, Song K, Branthwaite HE, Erickson KR, Mukerjee S, Nolan SO, Siciliano CA. Systemic kappa opioid receptor antagonism accelerates reinforcement learning via augmentation of novelty processing in male mice. Neuropsychopharmacology 2023. [PMID: 36804487 DOI: 10.1038/s41386-023-01547-x] [Reference Citation Analysis]
2 Boinpally R, McGeeney D, Kaczynski E, Weissman D. An Open-Label Study to Evaluate the Effect of Eluxadoline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Participants. Clin Pharmacol Drug Dev 2022;11:1341-8. [PMID: 35938453 DOI: 10.1002/cpdd.1150] [Reference Citation Analysis]
3 Meqbil YJ, Rijn RMV. Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors. Pharmaceuticals (Basel) 2022;15:873. [PMID: 35890173 DOI: 10.3390/ph15070873] [Reference Citation Analysis]
4 Lu Y, Huang J, Zhang Y, Huang Z, Yan W, Zhou T, Wang Z, Liao L, Cao H, Tan B. Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle. Front Pharmacol 2021;12:596686. [PMID: 34594213 DOI: 10.3389/fphar.2021.596686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Hu S, Dan W, Liu J, Ha P, Zhou T, Guo X, Hou W. The Use of Traditional Chinese Medicine in Relieving EGFR-TKI-Associated Diarrhea Based on Network Pharmacology and Data Mining. Evid Based Complement Alternat Med 2021;2021:5530898. [PMID: 33868436 DOI: 10.1155/2021/5530898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Maruca A, Lupia A, Rocca R, Keszthelyi D, Corsetti M, Alcaro S. In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal. Int J Mol Sci 2020;21:E9127. [PMID: 33266221 DOI: 10.3390/ijms21239127] [Reference Citation Analysis]
7 Hearn M, Whorwell PJ, Vasant DH. Stigma and irritable bowel syndrome: a taboo subject? The Lancet Gastroenterology & Hepatology 2020;5:607-15. [DOI: 10.1016/s2468-1253(19)30348-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
8 Corsetti M, Pannemans J, Whorwell P. Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders? F1000Res 2019;8:F1000 Faculty Rev-257. [PMID: 30863534 DOI: 10.12688/f1000research.15974.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhou TR, Huang JJ, Huang ZT, Cao HY, Tan B. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2018; 24(6): 693-705 [PMID: 29456408 DOI: 10.3748/wjg.v24.i6.693] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
10 Fragkos KC. Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea. Clin Exp Gastroenterol 2017;10:229-40. [PMID: 28989282 DOI: 10.2147/CEG.S123621] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]